Literature DB >> 17360495

Ischemic insults promote epigenetic reprogramming of mu opioid receptor expression in hippocampal neurons.

Luigi Formisano1, Kyung-Min Noh, Takahiro Miyawaki, Toshihiro Mashiko, Michael V L Bennett, R Suzanne Zukin.   

Abstract

Transient global ischemia is a neuronal insult that induces delayed, selective death of hippocampal CA1 pyramidal neurons. A mechanism underlying ischemia-induced cell death is activation of the gene silencing transcription factor REST (repressor element-1 silencing transcription factor)/NRSF (neuron-restrictive silencing factor) and REST-dependent suppression of the AMPA receptor subunit GluR2 in CA1 neurons destined to die. Here we show that REST regulates an additional gene target, OPRM1 (mu opioid receptor 1 or MOR-1). MORs are abundantly expressed by basket cells and other inhibitory interneurons of CA1. Global ischemia induces a marked decrease in MOR-1 mRNA and protein expression that is specific to the selectively vulnerable area CA1, as assessed by quantitative real-time RT-PCR, Western blotting, and ChIP. We further show that OPRM1 gene silencing is REST-dependent and occurs via epigenetic modifications. Ischemia promotes deacetylation of core histone proteins H3 and H4 and dimethylation of histone H3 at lysine-9 (H3-K9) over the MOR-1 promoter, an signature of epigenetic gene silencing. Acute knockdown of MOR-1 gene expression by administration of antisense oligodeoxynucleotides to hippocampal slices in vitro or injection of the MOR antagonist naloxone to rats in vivo affords protection against ischemia-induced death of CA1 pyramidal neurons. These findings implicate MORs in ischemia-induced death of CA1 pyramidal neurons and document epigenetic remodeling of expression of OPRM1 in CA1 inhibitory interneurons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360495      PMCID: PMC1820727          DOI: 10.1073/pnas.0611704104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  CoREST is an integral component of the CoREST- human histone deacetylase complex.

Authors:  A You; J K Tong; C M Grozinger; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Identification of a neurorestrictive suppressor element (NRSE) in the human mu-opioid receptor gene.

Authors:  M L Andria; E J Simon
Journal:  Brain Res Mol Brain Res       Date:  2001-07-13

3.  Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR.

Authors:  Michael W Pfaffl; Graham W Horgan; Leo Dempfle
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

4.  Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study.

Authors:  Sabine Bahn; Michael Mimmack; Margaret Ryan; Maeve A Caldwell; Eric Jauniaux; Michael Starkey; Clive N Svendsen; Piers Emson
Journal:  Lancet       Date:  2002-01-26       Impact factor: 79.321

5.  Regulation of neuronal traits by a novel transcriptional complex.

Authors:  N Ballas; E Battaglioli; F Atouf; M E Andres; J Chenoweth; M E Anderson; C Burger; M Moniwa; J R Davie; W J Bowers; H J Federoff; D W Rose; M G Rosenfeld; P Brehm; G Mandel
Journal:  Neuron       Date:  2001-08-16       Impact factor: 17.173

Review 6.  Protein modules that manipulate histone tails for chromatin regulation.

Authors:  R Marmorstein
Journal:  Nat Rev Mol Cell Biol       Date:  2001-06       Impact factor: 94.444

7.  Mu opioid receptors are in discrete hippocampal interneuron subpopulations.

Authors:  Carrie T Drake; Teresa A Milner
Journal:  Hippocampus       Date:  2002       Impact factor: 3.899

8.  Knockout of the mu opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons.

Authors:  G C Harburg; F S Hall; A V Harrist; I Sora; G R Uhl; A J Eisch
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

9.  Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3.

Authors:  M Tachibana; K Sugimoto; T Fukushima; Y Shinkai
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

10.  Dynorphin A(1-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.

Authors:  Robert M Silva; Henya C Grossman; Maria M Hadjimarkou; Grace C Rossi; Gavril W Pasternak; Richard J Bodnar
Journal:  J Pharmacol Exp Ther       Date:  2002-05       Impact factor: 4.030

View more
  64 in total

1.  Eradicating the mediators of neuronal death with a fine-tooth comb.

Authors:  R Suzanne Zukin
Journal:  Sci Signal       Date:  2010-06-08       Impact factor: 8.192

Review 2.  In PC12 cells, expression of neurosecretion and neurite outgrowth are governed by the transcription repressor REST/NRSF.

Authors:  Rosalba D'Alessandro; Jacopo Meldolesi
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

Review 3.  REST and CoREST are transcriptional and epigenetic regulators of seminal neural fate decisions.

Authors:  Irfan A Qureshi; Solen Gokhan; Mark F Mehler
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

Review 4.  Transcriptional and epigenetic regulation of opioid receptor genes: present and future.

Authors:  Li-Na Wei; Horace H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

5.  Role of Kv4.3 in Vibration-Induced Muscle Pain in the Rat.

Authors:  Lindsay B Conner; Pedro Alvarez; Oliver Bogen; Jon D Levine
Journal:  J Pain       Date:  2015-12-22       Impact factor: 5.820

Review 6.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

7.  Chromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Transl Stroke Res       Date:  2011-03-01       Impact factor: 6.829

Review 8.  Epigenetic mechanisms in stroke and epilepsy.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Neuropsychopharmacology       Date:  2012-08-15       Impact factor: 7.853

Review 9.  The emerging field of epigenetics in neurodegeneration and neuroprotection.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

Review 10.  Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders.

Authors:  Ted Abel; R Suzanne Zukin
Journal:  Curr Opin Pharmacol       Date:  2008-02       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.